Click image to enlarge
-
-
Specifications
-
Kit Contents
-
Documentation
-
References
Application(s)
|
|
Phosphoproteins
,
Intracellular Signaling
|
|
Analyte(s)
|
|
STAT3
|
|
Species
|
|
Human, Mouse, Rat
|
|
Instrument(s)
|
|
SECTOR Imager 2400
,
MESO SECTOR S 600MM
,
SECTOR Imager 6000
,
MESO QuickPlex SQ 120MM
,
MESO QuickPlex SQ 120
,
MESO SECTOR S 600
|
|
Plate Type
|
|
96-well
|
|
Usage Statement
|
|
For Research Use Only. Not for use in diagnostic procedures.
|
|
Storage Condition
|
|
Multi-Component
|
|
Schedule B Code
|
|
3822.19.0000
|
|
Product Description
|
Storage
|
Quantity per Kit
|
Phosphatase Inhibitor I 0.1 mL
|
2-8 °C
|
1 each (0.1 mL)
|
|
Phosphatase Inhibitor II 0.1 mL
|
2-8 °C
|
1 each (1 each)
|
|
Protease Inhibitor Solution 0.1 mL
|
2-8 °C
|
1 each (1 each)
|
|
SULFO-TAG Anti-Phospho-STAT3 (Tyr705) Antibody
|
2-8 °C
|
1 vial (1 vial)
|
|
STAT3 Plate
|
2-8 °C
|
1 each (1 each)
|
|
|
2-8 °C
|
1 bottle (50 mL)
|
|
|
2-8 °C
|
1 bottle (200 mL)
|
|
|
RT
|
1 bottle (50 mL)
|
|
|
RT
|
1 bottle (15 g)
|
|
Product Description
|
Storage
|
Quantity per Kit
|
Phosphatase Inhibitor I 0.5mL
|
2-8 °C
|
1 each (1 each)
|
|
Phosphatase Inhibitor II 0.5mL
|
2-8 °C
|
1 each (1 each)
|
|
Protease Inhibitor Solution 0.5mL
|
2-8 °C
|
1 each (1 each)
|
|
SULFO-TAG Anti-Phospho-STAT3 (Tyr705) Antibody
|
2-8 °C
|
1 vial
|
|
STAT3 Plate
|
2-8 °C
|
5 each (1 each)
|
|
|
2-8 °C
|
1 bottle (50 mL)
|
|
|
2-8 °C
|
1 bottle (200 mL)
|
|
|
RT
|
1 bottle (50 mL)
|
|
|
RT
|
1 bottle (15 g)
|
|
Product Description
|
Storage
|
Quantity per Kit
|
Phosphatase Inhibitor I 0.5mL
|
2-8 °C
|
5 each (1 each)
|
|
Phosphatase Inhibitor II 0.5mL
|
2-8 °C
|
5 each (1 each)
|
|
Protease Inhibitor Solution 0.5mL
|
2-8 °C
|
5 each (1 each)
|
|
SULFO-TAG Anti-Phospho-STAT3 (Tyr705) Antibody
|
2-8 °C
|
5 vial
|
|
STAT3 Plate
|
2-8 °C
|
25 each (1 each)
|
|
|
2-8 °C
|
5 bottle (50 mL)
|
|
|
2-8 °C
|
5 bottle (200 mL)
|
|
|
RT
|
5 bottle (50 mL)
|
|
|
RT
|
5 bottle (15 g)
|
|
Product Inserts
|
|
|
Product Highlights
|
|
|
Certificate of analysis
|
|
|
SDS
|
|
|
Title
|
Journal
|
Year
|
|
A randomized, placebo-controlled study of the pharmacokinetics, pharmacodynamics, and tolerability of the oral JAK2 inhibitor fedratinib (SAR302503) in healthy volunteers.
|
|
|
|
Characterization of a high-affinity human antibody with a disulfide bridge in the third complementarity-determining region of the heavy chain.
|
|
|
|
Mechanism of anti-glioma activity and in vivo efficacy of the cannabinoid ligand KM-233.
|
|
|
|
Development and Utilization of Activated STAT3 Detection Assays for Screening a Library of Secreted Proteins.
|
|
|
|
Cooperative signaling through the signal transducer and activator of transcription 3 and nuclear factor-{kappa}B pathways in subtypes of diffuse large B-cell lymphoma.
|
|
|
|
|
Order Details
Catalog No
Size
Price in USD
Qty
Customer Service/Orders
Scientific/Technical Support
Instrument Support
Company Headquarters